Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4–10 and inhibit cytotoxicity and fibrillogenesis
Nature Medicine2002Vol. 8(11), pp. 1263–1269
Citations Over TimeTop 1% of 2002 papers
JoAnne McLaurin, Roxana Cecal, Meredith E. Kierstead, Tian Xu, Amie L. Phinney, Marilena Manea, J.E. French, Mark H. L. Lambermon, Audrey A. Darabie, Mary E. Brown, Christopher Janus, M. Azhar Chishti, Patrick Horne, David Westaway, Paul E. Fraser, Howard T.J. Mount, Michael Przybylski, Peter St George‐Hyslop
Related Papers
- → SIRT1 transgenic mice show phenotypes resembling calorie restriction(2007)708 cited
- → Transgenic mice: beyond the knockout(2010)24 cited
- → Early Changes in Behavior Deficits, Amyloid β-42 Deposits and MAPK Activation in Doubly Transgenic Mice Co-expressing NSE-Controlled Human Mutant PS2 and APPsw(2005)6 cited
- → Development and Characterization of Thy*IκBα-SI Transgenic Mice(2010)1 cited
- [Transgenic mice in basic research].(1998)